Nyumbani › Uzito Kupita Kiasi › Arizona › Phoenix
Majaribio ya kliniki ya Uzito Kupita Kiasi katika Phoenix, AZ
Masomo 15 ya Uzito Kupita Kiasi yanatafuta washiriki katika vituo vya Phoenix na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
InaajiriHatua 3
- Absolute Clinical Research, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
InaajiriHatua 3
- RIO Clinical Trials - Phoenix, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
InaajiriHatua 3
- Research Site, Phoenix
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
InaajiriHatua 3
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
InaajiriHatua 3
- Elite Clinical Studies, LLC, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
InaajiriHatua 3
- AURORA-1 Clinical Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
InaajiriHatua 3
- AURORA-2 Clinical Site, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
InaajiriHatua 2
- Helios Clinical Research - Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
InaajiriHatua 3Wajitolea wenye afya wanakaribishwa
- ACCOMPLISH-2 Research Site, Phoenix
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
InaajiriHatua 2
- Synexus Clinical Research US, Inc., Phoenix
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
InaajiriHatua 4
- Medical Dermatology Specialists, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
InaajiriHatua 3
- Kailera Clinical Site, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
InaajiriUtafiti wa uchunguzi
- Exponent Phoenix, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
InaajiriHatua 3
- ACCOMPLISH-1 Research Site, Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
InaajiriHatua 3
- The University of Arizona College of Medicine- Phoenix, Phoenix
Majaribio ya Uzito Kupita Kiasi katika miji mingine
- San Antonio, TXUtafiti 34
- Houston, TXUtafiti 33
- Chicago, ILUtafiti 28
- Orlando, FLUtafiti 27
- Las Vegas, NVUtafiti 23
- Miami, FLUtafiti 23
- Atlanta, GAUtafiti 20
- Dallas, TXUtafiti 20
- New York City, NYUtafiti 19
- Jacksonville, FLUtafiti 19
- Washington, DCUtafiti 19
- Austin, TXUtafiti 18
Masomo mengine katika Phoenix
- Saratani ya MatitiUtafiti 25
- Kansari ya kolorektaliUtafiti 25
- UnenepuUtafiti 22
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 20
- Saratani ya MetastasiUtafiti 20
- Kushindwa kwa MoyoUtafiti 18
- Saratani ya ProstateUtafiti 17
- Saratani (aina zote)Utafiti 17
- Multiple MyelomaUtafiti 16
- Kansari ya PancreasUtafiti 16
- Magonjwa ya Moyo na Mishipa ya DamuUtafiti 16
- Ugonjwa wa AlzheimerUtafiti 15
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.